Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Hatch, CD; Lund, BC; Perry, PJ
   Failed challenge with quetiapine after neuroleptic malignant syndrome withconventional antipsychotics
   PHARMACOTHERAPY
   
   C.D. Hatch et al., "Failed challenge with quetiapine after neuroleptic malignant syndrome withconventional antipsychotics", PHARMACOTHE, 21(8), 2001, pp. 1003-1006
2. Carnahan, RM; Lund, BC; Perry, PJ
   Ziprasidone, a new atypical antipsychotic drug
   PHARMACOTHERAPY
   
   R.M. Carnahan et al., "Ziprasidone, a new atypical antipsychotic drug", PHARMACOTHE, 21(6), 2001, pp. 717-730
3. Perry, PJ; Lund, BC; Sanger, T; Besley, C
   Olanzapine plasma concentrations and clinical response: Acute phase results of the North American Olanzapine Trial
   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
   
   P.J. Perry et al., "Olanzapine plasma concentrations and clinical response: Acute phase results of the North American Olanzapine Trial", J CL PSYCH, 21(1), 2001, pp. 14-20
4. Lund, BC; Perry, PJ; Brooks, JM; Arndt, S
   Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension - A claims-based approach
   ARCHIVES OF GENERAL PSYCHIATRY
   
   B.C. Lund et al., "Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension - A claims-based approach", ARCH G PSYC, 58(12), 2001, pp. 1172-1176
5. Lund, BC; Perry, PJ; Miller, DD
   Treating depression in schizophrenia
   AMERICAN JOURNAL OF PSYCHIATRY
   
   B.C. Lund et al., "Treating depression in schizophrenia", AM J PSYCHI, 158(9), 2001, pp. 1528-1528
6. Perry, PJ
   Therapeutic drug monitoring of atypical antipsychotics - Is it of potential clinical value?
   CNS DRUGS
   
   P.J. Perry, "Therapeutic drug monitoring of atypical antipsychotics - Is it of potential clinical value?", CNS DRUGS, 13(3), 2000, pp. 167-171
7. Long, TD; Ellingrod, VL; Kathol, RG; Christensen, LE; Resch, DS; Perry, PJ
   Lack of menstrual cycle effects on hypothalamic-pituitary-adrenal axis response to insulin-induced hypoglycaemia
   CLINICAL ENDOCRINOLOGY
   
   T.D. Long et al., "Lack of menstrual cycle effects on hypothalamic-pituitary-adrenal axis response to insulin-induced hypoglycaemia", CLIN ENDOCR, 52(6), 2000, pp. 781-787
8. Wehring, H; Alexander, B; Perry, PJ
   Diabetes mellitus associated with clozapine therapy
   PHARMACOTHERAPY
   
   H. Wehring et al., "Diabetes mellitus associated with clozapine therapy", PHARMACOTHE, 20(7), 2000, pp. 844-847
9. Perry, PJ; Bever-Stille, KA; Arndt, S; Gundersen, S
   Correlation of valproate plasma concentrations and dose in bipolar affective disorder
   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
   
   P.J. Perry et al., "Correlation of valproate plasma concentrations and dose in bipolar affective disorder", J CL PSYCH, 20(2), 2000, pp. 277-279
10. Stille, KAB; Perry, PJ
    Benefits of olanzapine as first-line schizophrenia therapy
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    
    K.A.B. Stille e P.J. Perry, "Benefits of olanzapine as first-line schizophrenia therapy", AM J HEAL S, 56(15), 1999, pp. 1560
11. Hadfield, JA; Pavlidis, VH; Perry, PJ; McGown, AT
    Synthesis and anticancer activities of 4-oxobenzopyrano[2,3-d]pyrimidines
    ANTI-CANCER DRUGS
    
    J.A. Hadfield et al., "Synthesis and anticancer activities of 4-oxobenzopyrano[2,3-d]pyrimidines", ANTI-CANC D, 10(6), 1999, pp. 591-595
12. Lund, BC; Bever-Stille, KA; Perry, PJ
    Testosterone and andropause: The feasibility of testosterone replacement therapy in elderly men
    PHARMACOTHERAPY
    
    B.C. Lund et al., "Testosterone and andropause: The feasibility of testosterone replacement therapy in elderly men", PHARMACOTHE, 19(8), 1999, pp. 951-956
13. Lund, BC; Neiman, RF; Perry, PJ
    Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosis
    PHARMACOTHERAPY
    
    B.C. Lund et al., "Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosis", PHARMACOTHE, 19(12), 1999, pp. 1437-1438
14. Perry, PJ; Sanger, T; Beasley, CM
    Plasma olanzapine and clinical response: Reply
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    
    P.J. Perry et al., "Plasma olanzapine and clinical response: Reply", J CL PSYCH, 19(2), 1999, pp. 193-194
15. Perry, PJ; Gowan, SM; Read, MA; Kelland, LR; Neidle, S
    Design, synthesis and evaluation of human telomerase inhibitors based upona tetracyclic structural motif
    ANTI-CANCER DRUG DESIGN
    
    P.J. Perry et al., "Design, synthesis and evaluation of human telomerase inhibitors based upona tetracyclic structural motif", ANTI-CAN DR, 14(4), 1999, pp. 373-382
16. Perry, PJ; Read, MA; Davies, RT; Gowan, SM; Reszka, AP; Wood, AA; Kelland, LR; Neidle, S
    2,7-disubstituted amidofluorenone derivatives as inhibitors of human telomerase
    JOURNAL OF MEDICINAL CHEMISTRY
    
    P.J. Perry et al., "2,7-disubstituted amidofluorenone derivatives as inhibitors of human telomerase", J MED CHEM, 42(14), 1999, pp. 2679-2684
17. Keppler, MD; Read, MA; Perry, PJ; Trent, JO; Jenkins, TC; Reszka, AP; Neidle, S; Fox, KR
    Stabilization of DNA triple helices by a series of mono- and disubstitutedamidoanthraquinones
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    M.D. Keppler et al., "Stabilization of DNA triple helices by a series of mono- and disubstitutedamidoanthraquinones", EUR J BIOCH, 263(3), 1999, pp. 817-825
18. Yates, WR; Perry, PJ; MacIndoe, J; Holman, T; Ellingrod, V
    Psychosexual effects of three doses of testosterone cycling in normal men
    BIOLOGICAL PSYCHIATRY
    
    W.R. Yates et al., "Psychosexual effects of three doses of testosterone cycling in normal men", BIOL PSYCHI, 45(3), 1999, pp. 254-260
19. Perry, PJ; Bever, KA; Alexander, B
    Serum level-monitoring strategies for antipsychotics, antidepressants, andantimanic agents
    PSYCHIATRIC TREATMENT OF THE MEDICALLY ILL
    
    P.J. Perry et al., "Serum level-monitoring strategies for antipsychotics, antidepressants, andantimanic agents", MED PSYCH, 13, 1999, pp. 479-497
20. Perry, PJ; Kelland, LR
    Telomeres and telomerase: targets for cancer chemotherapy?
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    P.J. Perry e L.R. Kelland, "Telomeres and telomerase: targets for cancer chemotherapy?", EXPERT OP T, 8(12), 1998, pp. 1567-1586
21. BEVER KA; PERRY PJ
    OLANZAPINE - A SEROTONIN-DOPAMINE-RECEPTOR ANTAGONIST FOR ANTIPSYCHOTIC THERAPY
    American journal of health-system pharmacy
    
    K.A. Bever e P.J. Perry, "OLANZAPINE - A SEROTONIN-DOPAMINE-RECEPTOR ANTAGONIST FOR ANTIPSYCHOTIC THERAPY", American journal of health-system pharmacy, 55(10), 1998, pp. 1003-1016
22. KELLAND LR; GOWAN SM; PERRY PJ; NEIDLE S
    INHIBITION OF HUMAN TELOMERASE AND GROWTH OF HUMAN OVARIAN-CARCINOMA CELL-LINES BY 2,6-DISUBSTITUTED AMIDO-ANTHRACENE-9,10 DIONES
    Annals of oncology
    
    L.R. Kelland et al., "INHIBITION OF HUMAN TELOMERASE AND GROWTH OF HUMAN OVARIAN-CARCINOMA CELL-LINES BY 2,6-DISUBSTITUTED AMIDO-ANTHRACENE-9,10 DIONES", Annals of oncology, 9, 1998, pp. 540-540
23. MIN DI; PERRY PJ; CHEN HY; HUNSICKER LG
    CYCLOSPORINE TROUGH CONCENTRATIONS IN PREDICTING ALLOGRAFT-REJECTION AND RENAL TOXICITY UP TO 12 MONTHS AFTER RENAL-TRANSPLANTATION
    Pharmacotherapy
    
    D.I. Min et al., "CYCLOSPORINE TROUGH CONCENTRATIONS IN PREDICTING ALLOGRAFT-REJECTION AND RENAL TOXICITY UP TO 12 MONTHS AFTER RENAL-TRANSPLANTATION", Pharmacotherapy, 18(2), 1998, pp. 282-287
24. COOPER CS; PERRY PJ; SPARKS AET; MACINDOE JH; YATES WR; WILLIAMS RD
    EFFECT OF EXOGENOUS TESTOSTERONE ON PROSTATE VOLUME, SERUM AND SEMEN PROSTATE-SPECIFIC ANTIGEN LEVELS IN HEALTHY-YOUNG MEN
    The Journal of urology
    
    C.S. Cooper et al., "EFFECT OF EXOGENOUS TESTOSTERONE ON PROSTATE VOLUME, SERUM AND SEMEN PROSTATE-SPECIFIC ANTIGEN LEVELS IN HEALTHY-YOUNG MEN", The Journal of urology, 159(2), 1998, pp. 441-443
25. PERRY PJ; RESZKA AP; WOOD AA; READ MA; GOWAN SM; DOSANJH HS; TRENT JO; JENKINS TC; KELLAND LR; NEIDLE S
    HUMAN TELOMERASE INHIBITION BY REGIOISOMERIC DISUBSTITUTED AMIDOANTHRACENE-9,10-DIONES
    Journal of medicinal chemistry
    
    P.J. Perry et al., "HUMAN TELOMERASE INHIBITION BY REGIOISOMERIC DISUBSTITUTED AMIDOANTHRACENE-9,10-DIONES", Journal of medicinal chemistry, 41(24), 1998, pp. 4873-4884
26. PERRY PJ; GOWAN SM; RESZKA AP; POLUCCI P; JENKINS TC; KELLAND LR; NEIDLE S
    1,4-DISUBSTITUTED AND 2,6-DISUBSTITUTED AMIDOANTHRACENE-9,10-DIONE DERIVATIVES AS INHIBITORS OF HUMAN TELOMERASE
    Journal of medicinal chemistry
    
    P.J. Perry et al., "1,4-DISUBSTITUTED AND 2,6-DISUBSTITUTED AMIDOANTHRACENE-9,10-DIONE DERIVATIVES AS INHIBITORS OF HUMAN TELOMERASE", Journal of medicinal chemistry, 41(17), 1998, pp. 3253-3260
27. PERRY PJ
    PRINCIPLES OF NEUROPSYCHOPHARMACOLOGY - FELDMAN,RS, MEYER,JS, QUENZER,LF
    Contemporary psychology
    
    P.J. Perry, "PRINCIPLES OF NEUROPSYCHOPHARMACOLOGY - FELDMAN,RS, MEYER,JS, QUENZER,LF", Contemporary psychology, 43(8), 1998, pp. 570-570
28. KELLAND LR; GOWAN SM; PERRY PJ; NEIDLE S
    2.6-DISUBSTITUTED AMIDO-ANTHRACENE-9,10 DIONES - SMALL-MOLECULE INHIBITORS OF HUMAN TELOMERASE
    British Journal of Cancer
    
    L.R. Kelland et al., "2.6-DISUBSTITUTED AMIDO-ANTHRACENE-9,10 DIONES - SMALL-MOLECULE INHIBITORS OF HUMAN TELOMERASE", British Journal of Cancer, 78, 1998, pp. 64-64
29. PERRY PJ; BEVER KA; ARNDT S; COMBS MD
    RELATIONSHIP BETWEEN PATIENT VARIABLES AND PLASMA CLOZAPINE CONCENTRATIONS - A DOSING NOMOGRAM
    Biological psychiatry
    
    P.J. Perry et al., "RELATIONSHIP BETWEEN PATIENT VARIABLES AND PLASMA CLOZAPINE CONCENTRATIONS - A DOSING NOMOGRAM", Biological psychiatry, 44(8), 1998, pp. 733-738
30. CORYELL W; MILLER DD; PERRY PJ
    HALOPERIDOL PLASMA-LEVELS AND DOSE OPTIMIZATION
    The American journal of psychiatry
    
    W. Coryell et al., "HALOPERIDOL PLASMA-LEVELS AND DOSE OPTIMIZATION", The American journal of psychiatry, 155(1), 1998, pp. 48-53
31. MACINDOE JH; PERRY PJ; YATES WR; HOLMAN TL; ELLINGROD VL; SCOTT SD
    TESTOSTERONE SUPPRESSION OF THE HPT AXIS
    Journal of investigative medicine
    
    J.H. Macindoe et al., "TESTOSTERONE SUPPRESSION OF THE HPT AXIS", Journal of investigative medicine, 45(8), 1997, pp. 441-447
32. BEVER KA; PERRY PJ
    DEXFENFLURAMINE HYDROCHLORIDE - AN ANOREXIGENIC AGENT
    American journal of health-system pharmacy
    
    K.A. Bever e P.J. Perry, "DEXFENFLURAMINE HYDROCHLORIDE - AN ANOREXIGENIC AGENT", American journal of health-system pharmacy, 54(18), 1997, pp. 2059-2072
33. PERRY PJ
    POLITICAL CORRUPTION - THE LAST GEOGRAPHICAL TABOO - COMMENT
    Political geography
    
    P.J. Perry, "POLITICAL CORRUPTION - THE LAST GEOGRAPHICAL TABOO - COMMENT", Political geography, 16(3), 1997, pp. 187-188
34. COMBS MD; PERRY PJ; BEVER KA
    N-DESMETHYLCLOZAPINE, AN INSENSITIVE MARKER OF CLOZAPINE-INDUCED AGRANULOCYTOSIS AND GRANULOCYTOPENIA
    Pharmacotherapy
    
    M.D. Combs et al., "N-DESMETHYLCLOZAPINE, AN INSENSITIVE MARKER OF CLOZAPINE-INDUCED AGRANULOCYTOSIS AND GRANULOCYTOPENIA", Pharmacotherapy, 17(6), 1997, pp. 1300-1304
35. PERRY PJ; SANGER T; BEASLEY C
    OLANZAPINE PLASMA-CONCENTRATIONS AND CLINICAL-RESPONSE IN ACUTELY ILLSCHIZOPHRENIC-PATIENTS
    Journal of clinical psychopharmacology
    
    P.J. Perry et al., "OLANZAPINE PLASMA-CONCENTRATIONS AND CLINICAL-RESPONSE IN ACUTELY ILLSCHIZOPHRENIC-PATIENTS", Journal of clinical psychopharmacology, 17(6), 1997, pp. 472-477
36. ELLINGROD VL; PERRY PJ; YATES WR; MACINDOE JH; WATSON G; ARNDT S; HOLMAN TL
    THE EFFECTS OF ANABOLIC-STEROIDS ON DRIVING PERFORMANCE AS ASSESSED BY THE IOWA DRIVER SIMULATOR
    The American journal of drug and alcohol abuse
    
    V.L. Ellingrod et al., "THE EFFECTS OF ANABOLIC-STEROIDS ON DRIVING PERFORMANCE AS ASSESSED BY THE IOWA DRIVER SIMULATOR", The American journal of drug and alcohol abuse, 23(4), 1997, pp. 623-636
37. PERRY PJ; PAVLIDIS VH; HADFIELD JA
    SYNTHESIS OF CYTOTOXIC FURONAPHTHOQUINONES - REGIOSPECIFIC SYNTHESIS OF DIODANTUNEZONE AND 2-ETHYLFURONAPHTHOQUINONES
    Tetrahedron
    
    P.J. Perry et al., "SYNTHESIS OF CYTOTOXIC FURONAPHTHOQUINONES - REGIOSPECIFIC SYNTHESIS OF DIODANTUNEZONE AND 2-ETHYLFURONAPHTHOQUINONES", Tetrahedron, 53(9), 1997, pp. 3195-3204
38. PERRY PJ; MACINDOE JH; YATES WR; SCOTT SD; HOLMAN TL
    DETECTION OF ANABOLIC-STEROID ADMINISTRATION - RATIO OF URINARY TESTOSTERONE TO EPITESTOSTERONE VS THE RATIO OF URINARY TESTOSTERONE TO LUTEINIZING-HORMONE
    Clinical chemistry
    
    P.J. Perry et al., "DETECTION OF ANABOLIC-STEROID ADMINISTRATION - RATIO OF URINARY TESTOSTERONE TO EPITESTOSTERONE VS THE RATIO OF URINARY TESTOSTERONE TO LUTEINIZING-HORMONE", Clinical chemistry, 43(5), 1997, pp. 731-735
39. ELLINGROD V; PERRY PJ
    REASSESSMENT OF NEFAZODONE
    American journal of health-system pharmacy
    
    V. Ellingrod e P.J. Perry, "REASSESSMENT OF NEFAZODONE", American journal of health-system pharmacy, 53(19), 1996, pp. 2340
40. BEASLEY CM; TOLLEFSON G; TRAN P; SATTERLEE W; SANGER T; HAMILTON S; FABRE L; SMALL J; ERESHEFSKY L; TRUE J; NEMEROFF C; RISCH SC; PERRY PJ; POTKIN SG; BORISON RL; JAMES S; MELTZER HY; IQBAL N; FANN WE; GEWIRTZ GR; LANDBLOOM R; ROYBYRNE PP; TUASON VB; CARMAN JS; STOKES PE; WILLIAMS R; ANCILL RJ; MACEWAN GW; GUJAVARTY KS; JONES B; LOHR JB
    OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - ACUTE-PHASE RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND OLANZAPINE TRIAL
    Neuropsychopharmacology
    
    C.M. Beasley et al., "OLANZAPINE VERSUS PLACEBO AND HALOPERIDOL - ACUTE-PHASE RESULTS OF THE NORTH-AMERICAN DOUBLE-BLIND OLANZAPINE TRIAL", Neuropsychopharmacology, 14(2), 1996, pp. 111-123
41. PERRY PJ; PAVLIDIS VH; NAIK M
    THE REGIOSPECIFIC C-3 LITHIATION OF 5-ETHYL-2-FUROIC ACID - AN APPROACH TO KEY NATURAL PRODUCT INTERMEDIATES
    Applied organometallic chemistry
    
    P.J. Perry et al., "THE REGIOSPECIFIC C-3 LITHIATION OF 5-ETHYL-2-FUROIC ACID - AN APPROACH TO KEY NATURAL PRODUCT INTERMEDIATES", Applied organometallic chemistry, 10(5), 1996, pp. 389-392
42. PERRY PJ
    PHARMACOTHERAPY FOR MAJOR DEPRESSION WITH MELANCHOLIC FEATURES - RELATIVE EFFICACY OF TRICYCLIC VERSUS SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANTS
    Journal of affective disorders
    
    P.J. Perry, "PHARMACOTHERAPY FOR MAJOR DEPRESSION WITH MELANCHOLIC FEATURES - RELATIVE EFFICACY OF TRICYCLIC VERSUS SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANTS", Journal of affective disorders, 39(1), 1996, pp. 1-6
43. MIN DI; KU YM; PERRY PJ; UKAH FO; ASHTON K; MARTIN MF; HUNSICKER LG
    EFFECT OF GRAPEFRUIT JUICE ON CYCLOSPORINE PHARMACOKINETICS IN RENAL-TRANSPLANT PATIENTS
    Transplantation
    
    D.I. Min et al., "EFFECT OF GRAPEFRUIT JUICE ON CYCLOSPORINE PHARMACOKINETICS IN RENAL-TRANSPLANT PATIENTS", Transplantation, 62(1), 1996, pp. 123-125
44. PERRY PJ; PAVLIDIS VH; COUTTS IGC
    THE RAPID REDUCTION OF ALPHA,ALPHA-DIARYL ALCOHOLS TO THE CORRESPONDING ALKANES USING IODOTRIMETHYLSILANE
    Synthetic communications
    
    P.J. Perry et al., "THE RAPID REDUCTION OF ALPHA,ALPHA-DIARYL ALCOHOLS TO THE CORRESPONDING ALKANES USING IODOTRIMETHYLSILANE", Synthetic communications, 26(1), 1996, pp. 101-111
45. COOPER CS; MACINDOE JH; PERRY PJ; YATES WR; WILLIAMS RD
    THE EFFECT OF EXOGENOUS TESTOSTERONE ON TOTAL AND FREE PROSTATE-SPECIFIC ANTIGEN LEVELS IN HEALTHY-YOUNG MEN
    The Journal of urology
    
    C.S. Cooper et al., "THE EFFECT OF EXOGENOUS TESTOSTERONE ON TOTAL AND FREE PROSTATE-SPECIFIC ANTIGEN LEVELS IN HEALTHY-YOUNG MEN", The Journal of urology, 156(2), 1996, pp. 438-441
46. COOPER CS; MACINDOE JH; PERRY PJ; YATES WR; WILLIAMS RD
    EFFECT OF EXOGENOUS TESTOSTERONE ON TOTAL AND FREE PROSTATE-SPECIFIC ANTIGEN LEVELS IN HEALTHY-YOUNG MEN - REPLY
    The Journal of urology
    
    C.S. Cooper et al., "EFFECT OF EXOGENOUS TESTOSTERONE ON TOTAL AND FREE PROSTATE-SPECIFIC ANTIGEN LEVELS IN HEALTHY-YOUNG MEN - REPLY", The Journal of urology, 156(2), 1996, pp. 442-442
47. YATES WR; PERRY PJ; ELLINGROD V
    STEROIDS
    The American journal of psychiatry
    
    W.R. Yates et al., "STEROIDS", The American journal of psychiatry, 153(12), 1996, pp. 1653-1653
48. PERRY PJ
    CLINICAL USE OF THE NEWER ANTIPSYCHOTIC-DRUGS
    American journal of health-system pharmacy
    
    P.J. Perry, "CLINICAL USE OF THE NEWER ANTIPSYCHOTIC-DRUGS", American journal of health-system pharmacy, 52(3), 1995, pp. 9-14
49. LAHTI AC; PERRY PJ; LOVE RC
    RECENT DEVELOPMENTS IN ANTIPSYCHOTIC THERAPY - QUESTIONS AND ANSWERS
    American journal of health-system pharmacy
    
    A.C. Lahti et al., "RECENT DEVELOPMENTS IN ANTIPSYCHOTIC THERAPY - QUESTIONS AND ANSWERS", American journal of health-system pharmacy, 52(3), 1995, pp. 19-20
50. ELLINGROD VL; PERRY PJ
    NEFAZODONE - A NEW ANTIDEPRESSANT
    American journal of health-system pharmacy
    
    V.L. Ellingrod e P.J. Perry, "NEFAZODONE - A NEW ANTIDEPRESSANT", American journal of health-system pharmacy, 52(24), 1995, pp. 2799-2812
51. ELLINGROD VL; PERRY PJ
    CLARIFICATION OF VENLAFAXINE CHEMISTRY, PHARMACOLOGY, AND PHARMACOKINETICS
    American journal of health-system pharmacy
    
    V.L. Ellingrod e P.J. Perry, "CLARIFICATION OF VENLAFAXINE CHEMISTRY, PHARMACOLOGY, AND PHARMACOKINETICS", American journal of health-system pharmacy, 52(14), 1995, pp. 1573-1574
52. CORYELL WH; MILLER DD; PERRY PJ
    THE CLINICAL UTILITY OF HALOPERIDOL PLASMA-LEVELS
    Schizophrenia research
    
    W.H. Coryell et al., "THE CLINICAL UTILITY OF HALOPERIDOL PLASMA-LEVELS", Schizophrenia research, 15(1-2), 1995, pp. 146-147
53. BARRICKMAN LL; PERRY PJ; ALLEN AJ; KUPERMAN S; ARNDT SV; HERRMANN KJ; SCHUMACHER E
    BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    Journal of the American Academy of Child and Adolescent Psychiatry
    
    L.L. Barrickman et al., "BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER", Journal of the American Academy of Child and Adolescent Psychiatry, 34(5), 1995, pp. 649-657
54. PERRY PJ; PAVLIDIS VH; HADFIELD JA; COUTTS IGC
    EFFICIENT REGIOSPECIFIC SYNTHESIS OF 2 CYTOTOXIC FURONAPHTHOQUINONES,DIMETHOXY-4,9-DIHYDRONAPHTHO[2,3-B]FURAN-4,9-DIONE AND RIMETHOXY-4,9-DIHYDRONAPHTHO[2,3-B]FURAN-4,9-DIONE
    Journal of the Chemical Society. Perkin transactions. I
    
    P.J. Perry et al., "EFFICIENT REGIOSPECIFIC SYNTHESIS OF 2 CYTOTOXIC FURONAPHTHOQUINONES,DIMETHOXY-4,9-DIHYDRONAPHTHO[2,3-B]FURAN-4,9-DIONE AND RIMETHOXY-4,9-DIHYDRONAPHTHO[2,3-B]FURAN-4,9-DIONE", Journal of the Chemical Society. Perkin transactions. I, (9), 1995, pp. 1085-1087
55. PERRY PJ
    NEW-ZEALAND BURNING - THE SETTLERS WORLD IN THE MID 1880S - ARNOLD,R
    Agricultural history review
    
    P.J. Perry, "NEW-ZEALAND BURNING - THE SETTLERS WORLD IN THE MID 1880S - ARNOLD,R", Agricultural history review, 43, 1995, pp. 108-109
56. GRABER MA; HOEHNS TB; PERRY PJ
    SERTRALINE-PHENELZINE DRUG-INTERACTION - A SEROTONIN SYNDROME REACTION
    The Annals of pharmacotherapy
    
    M.A. Graber et al., "SERTRALINE-PHENELZINE DRUG-INTERACTION - A SEROTONIN SYNDROME REACTION", The Annals of pharmacotherapy, 28(6), 1994, pp. 732-735
57. HADFIELD JA; PAVLIDIS VH; MCGOWN AT; WHITWORTH C; PERRY PJ; FOX BW
    STRUCTURE-ACTIVITY STUDIES ON 2-ARYL-4H-3,1-BENZOXAZIN-4-ONES
    Anti-cancer drugs
    
    J.A. Hadfield et al., "STRUCTURE-ACTIVITY STUDIES ON 2-ARYL-4H-3,1-BENZOXAZIN-4-ONES", Anti-cancer drugs, 5(5), 1994, pp. 533-538
58. PERRY PJ; ZEILMANN C; ARNDT S
    TRICYCLIC ANTIDEPRESSANT CONCENTRATIONS IN PLASMA - AN ESTIMATE OF THEIR SENSITIVITY AND SPECIFICITY AS A PREDICTOR OF RESPONSE
    Journal of clinical psychopharmacology
    
    P.J. Perry et al., "TRICYCLIC ANTIDEPRESSANT CONCENTRATIONS IN PLASMA - AN ESTIMATE OF THEIR SENSITIVITY AND SPECIFICITY AS A PREDICTOR OF RESPONSE", Journal of clinical psychopharmacology, 14(4), 1994, pp. 230-240
59. MILLER DD; FLEMIGN F; HOLMAN TL; PERRY PJ
    PLASMA CLOZAPINE CONCENTRATIONS AS A PREDICTOR OF CLINICAL-RESPONSE -A FOLLOW-UP-STUDY
    The Journal of clinical psychiatry
    
    D.D. Miller et al., "PLASMA CLOZAPINE CONCENTRATIONS AS A PREDICTOR OF CLINICAL-RESPONSE -A FOLLOW-UP-STUDY", The Journal of clinical psychiatry, 55(9), 1994, pp. 117-121
60. PERRY PJ
    CORRUPTION AND GEOGRAPHY - A FABLE
    Applied geography
    
    P.J. Perry, "CORRUPTION AND GEOGRAPHY - A FABLE", Applied geography, 14(4), 1994, pp. 291-293
61. PAVLIDIS VH; PERRY PJ
    THE SYNTHESIS OF A NOVEL SERIES OF SUBSTITUTED 2-PHENYL-4H-3,1-BENZOXAZIN-4-ONES
    Synthetic communications
    
    V.H. Pavlidis e P.J. Perry, "THE SYNTHESIS OF A NOVEL SERIES OF SUBSTITUTED 2-PHENYL-4H-3,1-BENZOXAZIN-4-ONES", Synthetic communications, 24(4), 1994, pp. 533-548
62. MILLER DD; PERRY PJ; CADORET RJ; ANDREASEN NC
    CLOZAPINES EFFECT ON NEGATIVE SYMPTOMS IN TREATMENT-REFRACTORY SCHIZOPHRENICS
    Comprehensive psychiatry
    
    D.D. Miller et al., "CLOZAPINES EFFECT ON NEGATIVE SYMPTOMS IN TREATMENT-REFRACTORY SCHIZOPHRENICS", Comprehensive psychiatry, 35(1), 1994, pp. 8-15
63. ELLINGROD VL; PERRY PJ
    VENLAFAXINE - A HETEROCYCLIC ANTIDEPRESSANT
    American journal of hospital pharmacy
    
    V.L. Ellingrod e P.J. Perry, "VENLAFAXINE - A HETEROCYCLIC ANTIDEPRESSANT", American journal of hospital pharmacy, 51(24), 1994, pp. 3033-3046
64. HOEHNS JD; PERRY PJ
    LOOK AGAIN AT INFORMATION ON ZOLPIDEM TARTRATE
    American journal of hospital pharmacy
    
    J.D. Hoehns e P.J. Perry, "LOOK AGAIN AT INFORMATION ON ZOLPIDEM TARTRATE", American journal of hospital pharmacy, 51(10), 1994, pp. 1356-1357
65. HOEHNS JD; PERRY PJ
    ZOLPIDEM - A NONBENZODIAZEPINE HYPNOTIC FOR TREATMENT OF INSOMNIA
    Clinical pharmacy
    
    J.D. Hoehns e P.J. Perry, "ZOLPIDEM - A NONBENZODIAZEPINE HYPNOTIC FOR TREATMENT OF INSOMNIA", Clinical pharmacy, 12(11), 1993, pp. 814-828